Thayer, Sarah <br/><br/>
The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy.  [electronic resource] 

 -  Advances in therapy  Dec 2013 
 - 1128-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-013-0074-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Glucose--analysis<br/>Cohort Studies<br/>Cost-Benefit Analysis<br/>Databases, Factual<br/>Diabetes Mellitus, Type 2--diagnosis<br/>Disposable Equipment--economics<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Glucagon-Like Peptide 1--administration & dosage<br/>Health Care Costs<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Injections, Subcutaneous<br/>Insulin Glargine<br/>Insulin, Long-Acting--administration & dosage<br/>Liraglutide<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Statistics, Nonparametric<br/>Syringes--economics<br/>Treatment Outcome<br/>United States